Verdict No. 3: Jury Awards $70M Against Johnson & Johnson in Cancer Link to Talcum Powder

Jim Onder is the senior member and founder of the law firm of Onder, Shelton, O'Leary & Peterson, LLC, in St. Louis.
Jim Onder is the senior member and founder of the law firm of Onder, Shelton, O’Leary & Peterson, LLC, in St. Louis.

For the third time this year, a jury in St. Louis has awarded an 8-figure verdict against Johnson & Johnson for failing to warn the public about the dangers that its talcum powder products can lead to ovarian cancer.

  • On October 27 the third jury awarded more than $70 million in damages to Deborah Giannecchini, 62, of Modesto, CA, on her claim that her use of baby powder and other Johnson & Johnson talc products over 40 years caused her ovarian cancer. She was diagnosed with stage 4 ovarian cancer in 2012 and talc was found in her ovaries.
  • In February, a jury awarded $72 million to the family of Jacqueline Fox of Birmingham, AL, who used Johnson’s baby powder for 35 years. She was diagnosed with ovarian cancer in 2013 and died last year.
  • In May another jury in the same courthouse awarded $55 million to Gloria Ristesund of Sioux Falls, SD. She was diagnosed with cancer in 2011 after using J&J’s talc-based feminine hygiene products for almost 40 years.

Long-known cancer risk

Plaintiff attorney Jim Onder of St. Louis, MO, represented all three women. He argued that studies have shown for 30 years that there is a link between talcum powder and ovarian cancer, but that J&J conspired to hide the truth.

Also read:

Behind the $55 Million Talc Verdict: J&J Knew About Cancer Risks Since the 1970s

Internal J&J memos showed the company was aware of studies linking talc powder to an increased risk of ovarian cancer for decades, according to Onder.

The Oct. 27 verdict also held Imerys Talc liable. Imerys supplied talc to J&J and placed health warnings on the material safety data sheets for the talc. J&J, however, has never put a health warning on its Baby Powder or Shower to Shower products.

J&J is facing nearly 2,000 lawsuits in Missouri and New Jersey, charging it with failing to warn consumers about the cancer risks:

The New Jersey dismissal makes the Giannecchini trial that much more significant, because it would likely make Missouri the preferred forum for newly filed talc cases.


Share this Post: